Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.
Curr Probl Cardiol. 2023 Jul;48(7):101680. doi: 10.1016/j.cpcardiol.2023.101680. Epub 2023 Mar 12.
We aimed to compare the characteristics and outcomes of adult patients hospitalized with myocarditis and either concomitant corona virus disease 2019 (COVID-19) or influenza, and elucidate clinical predictors associated with adverse outcomes in both groups. The study used the national inpatient sample (NIS) from 2019 to 2020 to identify 27,725 adult myocarditis hospitalizations, of which 5840 had concomitant COVID-19 and 1045 had concomitant influenza. After propensity score matching, the in-hospital mortality from myocarditis was significantly higher in COVID-19 compared to influenza. Patients with myocarditis and COVID-19 were more likely to have cardiovascular comorbidities and be older than those with influenza-associated myocarditis. Predictors of mortality were also different in both groups.
我们旨在比较合并新型冠状病毒病 2019（COVID-19）或流感的心肌炎成年患者的特征和结局，并阐明两组中与不良结局相关的临床预测因素。该研究使用了 2019 年至 2020 年的全国住院患者样本（NIS），共确定了 27725 例成年心肌炎住院患者，其中 5840 例合并 COVID-19，1045 例合并流感。在进行倾向评分匹配后，COVID-19 合并心肌炎患者的住院死亡率明显高于流感。与流感相关的心肌炎患者相比，COVID-19 合并心肌炎患者更有可能合并心血管合并症且年龄更大。两组的死亡预测因素也不同。
